International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 8/31/2024 | 8/31/2023 | 8/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.98 | 0.01 | -0.29 | 0.07 |
| FCF Yield | 0.00% | 17.47% | 10.45% | 0.42% |
| EV / EBITDA | -12,103.60 | 6.88 | 0.00 | 0.00 |
| Quality | ||||
| ROIC | -0.07% | 11.98% | 1.92% | -4.76% |
| Gross Margin | 76.97% | 94.81% | 72.64% | -61.34% |
| Cash Conversion Ratio | -24.47 | 1.17 | 3.94 | -0.05 |
| Growth | ||||
| Revenue 3-Year CAGR | 30.06% | 24.12% | -33.68% | -26.00% |
| Free Cash Flow Growth | -100.00% | 66.13% | 2,328.74% | 107.73% |
| Safety | ||||
| Net Debt / EBITDA | -696.52 | 0.31 | 0.00 | 0.00 |
| Interest Coverage | 0.00 | 17.99 | 5.30 | -26.06 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 1.29 | -309.92 | 94.38 | 43.89 |